Canadian biopharma companies are capitalizing on increased government investment stimulated by the recent pandemic to strengthen domestic capabilities and foster multinational partnerships that enhance drug discovery and development worldwide. Canada has long punched above its weight in life sciences and biotechnology, with many of the fundamental discoveries that underpin today’s important blockbuster drugs and therapeutic […]